Soleno Therapeutics Stock Price Patterns
| SLNO Stock | USD 38.56 1.99 4.91% |
Momentum 33
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter 0.215 | EPS Estimate Current Year 0.2883 | EPS Estimate Next Year 4.3025 | Wall Street Target Price 111.9231 | EPS Estimate Current Quarter 0.0575 |
Using Soleno Therapeutics hype-based prediction, you can estimate the value of Soleno Therapeutics from the perspective of Soleno Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Soleno Therapeutics using Soleno Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Soleno using crowd psychology based on the activity and movement of Soleno Therapeutics' stock price.
Soleno Therapeutics Short Interest
An investor who is long Soleno Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Soleno Therapeutics and may potentially protect profits, hedge Soleno Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 65.569 | Short Percent 0.2435 | Short Ratio 7.28 | Shares Short Prior Month 10.9 M | 50 Day MA 46.7215 |
Soleno Therapeutics Hype to Price Pattern
Investor biases related to Soleno Therapeutics' public news can be used to forecast risks associated with an investment in Soleno. The trend in average sentiment can be used to explain how an investor holding Soleno can time the market purely based on public headlines and social activities around Soleno Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Soleno Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Soleno Therapeutics.
Soleno Therapeutics Implied Volatility | 0.73 |
Soleno Therapeutics' implied volatility exposes the market's sentiment of Soleno Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Soleno Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Soleno Therapeutics stock will not fluctuate a lot when Soleno Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Soleno Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Soleno because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Soleno Therapeutics after-hype prediction price | USD 35.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Soleno contract
Based on the Rule 16, the options market is currently suggesting that Soleno Therapeutics will have an average daily up or down price movement of about 0.0456% per day over the life of the 2026-03-20 option contract. With Soleno Therapeutics trading at USD 38.56, that is roughly USD 0.0176 . If you think that the market is fully incorporating Soleno Therapeutics' daily price movement you should consider acquiring Soleno Therapeutics options at the current volatility level of 0.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Soleno Therapeutics Basic Forecasting Models to cross-verify your projections. Soleno Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Soleno Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Soleno Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Soleno Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Soleno Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Soleno Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Soleno Therapeutics' historical news coverage. Soleno Therapeutics' after-hype downside and upside margins for the prediction period are 30.93 and 40.31, respectively. We have considered Soleno Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Soleno Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Soleno Therapeutics is based on 3 months time horizon.
Soleno Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Soleno Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Soleno Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Soleno Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.75 | 4.69 | 2.94 | 0.15 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
38.56 | 35.62 | 7.62 |
|
Soleno Therapeutics Hype Timeline
Soleno Therapeutics is at this time traded for 38.56. The entity has historical hype elasticity of -2.94, and average elasticity to hype of competition of -0.15. Soleno is estimated to decline in value after the next headline, with the price expected to drop to 35.62. The average volatility of media hype impact on the company price is about 119.64%. The price decrease on the next news is expected to be -7.62%, whereas the daily expected return is at this time at -0.75%. The volatility of related hype on Soleno Therapeutics is about 2405.13%, with the expected price after the next announcement by competition of 38.41. About 98.0% of the company shares are owned by institutional investors. The book value of Soleno Therapeutics was at this time reported as 9.21. The company recorded a loss per share of 1.75. Soleno Therapeutics had 1:15 split on the 26th of August 2022. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out Soleno Therapeutics Basic Forecasting Models to cross-verify your projections.Soleno Therapeutics Related Hype Analysis
Having access to credible news sources related to Soleno Therapeutics' direct competition is more important than ever and may enhance your ability to predict Soleno Therapeutics' future price movements. Getting to know how Soleno Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Soleno Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRAX | Praxis Precision Medicines | (3.51) | 8 per month | 3.95 | 0.17 | 9.33 | (6.06) | 36.21 | |
| DYN | Dyne Therapeutics | (0.37) | 11 per month | 4.71 | 0.04 | 7.01 | (5.90) | 58.12 | |
| AAPG | Ascentage Pharma Group | (2.39) | 9 per month | 0.00 | (0.16) | 5.25 | (6.36) | 16.72 | |
| APGE | Apogee Therapeutics Common | 1.96 | 8 per month | 2.43 | 0.13 | 4.56 | (2.64) | 23.21 | |
| CNTA | Centessa Pharmaceuticals PLC | (0.03) | 9 per month | 2.65 | 0.01 | 4.97 | (4.08) | 26.54 | |
| XENE | Xenon Pharmaceuticals | (2.30) | 11 per month | 1.93 | (0) | 3.78 | (2.71) | 10.56 | |
| RARE | Ultragenyx | (0.95) | 12 per month | 0.00 | (0.05) | 7.73 | (4.09) | 51.23 | |
| MIRM | Mirum Pharmaceuticals | 3.56 | 9 per month | 1.73 | 0.21 | 4.60 | (3.38) | 13.83 | |
| CELC | Celcuity LLC | 3.25 | 9 per month | 2.02 | 0.21 | 7.55 | (2.93) | 17.89 | |
| VKTX | Viking Therapeutics | (1.17) | 27 per month | 0.00 | (0.05) | 7.49 | (5.49) | 19.06 |
Soleno Therapeutics Additional Predictive Modules
Most predictive techniques to examine Soleno price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Soleno using various technical indicators. When you analyze Soleno charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Soleno Therapeutics Predictive Indicators
The successful prediction of Soleno Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Soleno Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Soleno Therapeutics based on analysis of Soleno Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Soleno Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Soleno Therapeutics's related companies. | 2025 | 2026 (projected) | Payables Turnover | 0.72 | 0.69 | Days Of Inventory On Hand | 183.66 | 174.48 |
Pair Trading with Soleno Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Soleno Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Soleno Stock
| 0.66 | EVGN | Evogene | PairCorr |
| 0.8 | IMNN | Imunon Inc | PairCorr |
| 0.64 | IPHA | Innate Pharma | PairCorr |
| 0.84 | LYRA | Lyra Therapeutics | PairCorr |
| 0.81 | MBIO | Mustang Bio | PairCorr |
Moving against Soleno Stock
| 0.54 | MRKR | Marker Therapeutics | PairCorr |
| 0.53 | MOLN | Molecular Partners | PairCorr |
| 0.5 | CING | Cingulate | PairCorr |
| 0.48 | ARWR | Arrowhead Pharmaceuticals | PairCorr |
| 0.47 | AEON | AEON Biopharma | PairCorr |
The ability to find closely correlated positions to Soleno Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Soleno Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Soleno Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Soleno Therapeutics to buy it.
The correlation of Soleno Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Soleno Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Soleno Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Soleno Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Soleno Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Will Biotechnology sector continue expanding? Could Soleno diversify its offerings? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Soleno Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Soleno Therapeutics requires distinguishing between market price and book value, where the latter reflects Soleno's accounting equity. The concept of intrinsic value—what Soleno Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Soleno Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Soleno Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.